Home NDC 73289-0089 PYQUVI
Product NDC 73289-0089
11-digit product format 732890089
Labeler code 73289
Product ID 73289-0089_39853cd7-c033-848f-e063-6294a90a49e4
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name deflazacort
Dosage form SUSPENSION
Route ORAL
Labeler Aucta Pharmaceuticals, Inc.
Application ANDA219417
Marketing category ANDA
Marketing start 2025-06-30
Substance DEFLAZACORT
Active strength 22.75 mg/mL
Pharmacologic classes Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A219417-001 PYQUVI DEFLAZACORT 22.75MG/ML SUSPENSION / ORAL AB 2025-06-30
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A219417-001 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A219417-001 PYQUVI 22.75MG/ML SUSPENSION / ORAL AB 2025-06-30 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A219417-001 PYQUVI 22.75MG/ML SUSPENSION / ORAL AB 2025-06-30 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A219417-001 PYQUVI 22.75MG/ML SUSPENSION / ORAL AB 2025-06-30 6a471c1ec25d…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A219417-001 PYQUVI 22.75MG/ML SUSPENSION / ORAL AB 2025-06-30 a50c72e98297…
Observed Orange Book normalized TE history# Captured, Edition, Application-product table Captured Edition Application-product TE code Order Source SHA-256 2026-02-19 14:30 UTC 2026-02 A219417-001 AB 1 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A219417-001 AB 1 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A219417-001 AB 1 6a471c1ec25d…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A219417-001 AB 1 a50c72e98297…
Additional Listing Data#
Finished product Yes
Brand name base PYQUVI
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength DEFLAZACORT 22.75 mg/mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination KR5YZ6AE4B Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 1870964 Internal RxNorm lookup 2719198 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 73289-0089-1 PYQUVI 13 mL in 1 BOTTLE SUSPENSION 13 1
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 73289-0089-1 73289008901 13 mL in 1 BOTTLE (73289-0089-1) 13 ml 2025-06-30 No No Current